規制動向

FDA、EMA、TGA および世界の規制動向

#Solvay ×

2026年9月28日•1分で読めます

FDA Discontinues Lactulose Oral/Rectal Solution (NDA017906)

The FDA has listed the Lactulose oral and rectal solution (product #001) as discontinued under NDA017906, sponsored by Solvay.

2026年9月23日•1分で読めます

SOLVAY's TRANMEP Tablet (Meprobamate 400mg) Discontinued – ANDA084369

FDA records show SOLVAY's oral tablet TRANMEP, containing 400 mg meprobamate, is listed as discontinued under application ANDA084369.

2026年9月3日•1分で読めます

FDA Approves ANDA083606 for Butabarital Sodium Oral Tablet

The FDA approved ANDA083606 for an oral tablet of butabarital sodium (16.2 mg) submitted by Solvay; the product is listed as discontinued.